Adding two culture-specific 'bolt-on' dimensions on the Thai version of EQ-5D-5L: an exploratory study in patients with diabetes [0.03%]
在泰国2型糖尿病患者中探索性地向EQ-5D-5L问卷中添加两个具有文化特异性的附加维度：一项横断面研究
Krittaphas Kangwanrattanakul,Cynthia R Gross,Montaya Sunantiwat et al.
Krittaphas Kangwanrattanakul et al.
Background: This study explored whether addition of culture-specific bolt-on dimensions, 'interpersonal relationships (IR)' and 'activities related to bending knees (AK)' improves the relevance and validity of the EQ-5D a...
Fair global drug pricing [0.03%]
公平的全球药物定价政策
Jonathan D Campbell,Zoltán Kaló
Jonathan D Campbell
Creating a personalized evaluation framework for patient-reported outcomes: an illustration using the EQ-5D visual analogue scale [0.03%]
创建针对患者报告结果的个性化评估框架：使用EQ-5D视觉模拟量表进行说明
M Reaney,L Stassek,M Martin et al.
M Reaney et al.
Background: This paper outlines the creation of an intuitive, personalized evaluation framework for Patient-Reported Outcomes, using the EQ-5D visual analog scale (VAS) as an illustration. ...
Consequences on economic outcomes of generic versus brand-name drugs used in routine clinical practice: the case of treating peripheral neuropathic pain or generalized anxiety disorder with pregabalin [0.03%]
用于临床实践的通用名药与品牌药对经济结果的影响：(pregabalin)治疗外周神经性疼痛或广泛性焦虑障碍的情况为例
Antoni Sicras-Mainar,Javier Rejas-Gutiérrez,María Pérez-Paramo et al.
Antoni Sicras-Mainar et al.
Background: Discrepancies are seen between arguments in favor of and against prescribing generic versus brand-name drugs. Objective: To...
Mapping the cancer-specific QLQ-C30 onto the generic EQ-5D-5L and SF-6D in colorectal cancer patients [0.03%]
将癌症专用QLQ-C30转化为结直肠癌患者的通用EQ-5D-5L和SF-6D
Hosein Ameri,Mahmood Yousefi,Mehdi Yaseri et al.
Hosein Ameri et al.
Introduction: Economic evaluation of healthcare interventions usually needs accurate data on utility and health-related quality-of-life scores. The aim of this study is to map QLQ-C30 scale score onto EQ-5D-5L and SF-6D u...
Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with vitamin K antagonists in patients with nonvalvular atrial fibrillation: a systematic literature review [0.03%]
一项系统性文献回顾：以维生素K拮抗剂为对照的新型口服抗凝药（利伐沙班、达比加群和阿哌沙班）在非瓣膜性房颤患者中的真实世界临床证据
Jean-Baptiste Briere,Kevin Bowrin,Craig Coleman et al.
Jean-Baptiste Briere et al.
Introduction: Several comparative real-world effectiveness studies on direct oral anticoagulants (DOACs) have been conducted, but an overview of the available evidence remains to be developed, which could provide a better...
Drug attributes associated with the selection of drugs for reimbursement: a pilot stated preferences experiment with Canadian stakeholders [0.03%]
与报销药物选择相关的药品属性：一项具有加拿大利益攸关方的声明偏爱实验试点项目
Wiesława Dominika Wranik,Christopher Skedgel,Min Hu
Wiesława Dominika Wranik
Introduction: Health Technologies Assessment requires that evidence about clinical, economic, social, and organizational aspects be considered and weighted in the selection of drugs for reimbursement. We investigate how e...
Cost analysis of type 2 diabetes mellitus treatment in economically developed countries [0.03%]
发达国家2型糖尿病治疗的成本分析
Sara Ramzan,Peter Timmins,Syed Shahzad Hasan et al.
Sara Ramzan et al.
Introduction: There is a growing need to evaluate the factors contributing to the increase in health expenditures, as well as the cost of medicines used in the treatment of Type 2 diabetes mellitus (T2DM) in the economica...
Adherence and resource use among psoriasis patients treated with biologics [0.03%]
生物制剂治疗银屑病患者的依从性及其资源利用状况分析
Joseph S Aleshaki,Leah A Cardwell,Mikél E Muse et al.
Joseph S Aleshaki et al.
Introduction: The emergence of immune-modulating drugs such as biologics has altered the treatment landscape for psoriasis. However, their use presents high financial costs to patients and healthcare systems. Patient demo...
Factors associated with physicians' decision to discontinue or down-titrate sulfonylureas for type 2 diabetes patients [0.03%]
与西格列汀联合二甲双胍治疗相关的因素会影响医生给2型糖尿病患者减量或停用磺脲类药物的决策的因素
Pedro Laires,Karen Kurtyka,Edward A Witt et al.
Pedro Laires et al.
Background: Sulfonylureas (SUs) can help manage type 2 diabetes mellitus, but often have side effects. The objective of this study was to identify factors impacting physicians' decisions to discontinue (DC) or down-titrat...